Â鶹´«Ã½

Skip to main content

U.S. FDA authorizes use of AstraZeneca COVID-19 antibody cocktail

In this image from undated video provided by AstraZeneca in December 2021, a worker packages the company's Evusheld medication. (AstraZeneca via AP) In this image from undated video provided by AstraZeneca in December 2021, a worker packages the company's Evusheld medication. (AstraZeneca via AP)
Share

The U.S. Food and Drug Administration on Wednesday authorized the use of AstraZeneca's antibody cocktail to prevent COVID-19 infections in individuals with weak immune systems or a history of severe side effects from coronavirus vaccines.

The antibody cocktail, Evusheld, is only authorized for adults and adolescents who are not currently infected with the novel coronavirus and have not recently been exposed to an infected individual, .

The authorization for the therapy, made up of two monoclonal antibodies tixagevimab and cilgavimab, marks a significant step for AstraZeneca, whose widely used COVID-19 vaccine is yet to be approved by U.S. authorities.

AstraZeneca last month had agreed to supply the U.S. government with 700,000 doses of Evusheld, which had earlier shown to cut the risk of people developing any COVID-19 symptoms by 77% in a late-stage trial.

While vaccines rely on an intact immune system to develop targeted antibodies and infection-fighting cells, Evusheld contains lab-made antibodies designed to linger in the body for months to contain the virus in case of an infection.

AstraZeneca's therapy, given in two sequential injections, is designed to last several months to a year.

Although vaccines currently provide the best defence against COVID-19, certain immune-compromised individuals or those who have a history of severe adverse reactions to a vaccine need an alternative prevention option, said Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research.

However, the FDA added that pre-exposure prevention with Evusheld is not a substitute for vaccination in individuals for whom COVID-19 vaccination is recommended.

Monoclonal antibodies aim to stop COVID-19 from worsening during early, milder stages. Drugmakers such as Eli Lilly, Regeneron, and GlaxoSmithKline with partner Vir make similar therapies.

(Reporting by Manas Mishra and Bhanvi Satija in Bengaluru; Editing by Shounak Dasgupta)

CTVNews.ca Top Stories

The sentencing of the man who pleaded guilty in the deadly hit-and-run in Kitsilano two years ago began on Friday.

WATCH LIVE @ 3:30 P.M.

WATCH LIVE @ 3:30 P.M.

The two people who died in a major fire in Old Montreal on Friday were a mother and her seven-year-old daughter, sources told Noovo Info.

Travelling on a budget can be stressful, but there are ways you can ensure you're getting the best deal on flights as the holiday season approaches.

Ontario Provincial Police have laid stunt charges against a driver caught speeding 75 km/h over the speed limit on Highway 417 in Ottawa's west end.

Canadian musician Jacob Hoggard has been found not guilty of sexually assaulting a young woman in northeastern Ontario eight years ago. The former Hedley frontman had pleaded not guilty to sexual assault.

Local Spotlight

Chantal Kreviazuk is set to return to Winnipeg to mark a major milestone in her illustrious musical career.

From the beaches of Cannes to the bustling streets of New York City, a new film by a trio of Manitoba directors has toured the international film festival circuit to much pomp and circumstance.

A husband and wife have been on the road trip of a lifetime and have decided to stop in Saskatchewan for the winter.

The grave of a previously unknown Canadian soldier has been identified as a man from Hayfield, Man. who fought in the First World War.

A group of classic car enthusiasts donated hundreds of blankets to nursing homes in Nova Scotia.

Moving into the second week of October, the eastern half of Canada can expect some brisker fall air to break down from the north

What does New Westminster's təməsew̓txʷ Aquatic and Community Centre have in common with a historic 68,000-seat stadium in Beijing, an NFL stadium and the aquatics venue for the Paris Olympics? They've all been named among the world's most beautiful sports venues for 2024.

The last living member of the legendary Vancouver Asahi baseball team, Kaye Kaminishi, died on Saturday, Sept. 28, surrounded by family. He was 102 years old.

New data from Greater Vancouver and the Fraser Valley shows a surge in supply and drop in demand in the region's historically hot real estate market.

Stay Connected